Radiation exposure does not appear to be associated with malignant intracranial tumors among radiologic technologists.
Radiologic technologists’ radiation exposure to the brain is not associated with malignant intracranial tumor mortality, according to a study published in the American Journal of Roentgenology. Researchers from Maryland, New York, Minnesota, and California sought to determine the association between protracted, low-to-moderate doses of radiation and malignant intracranial tumor mortality among radiologic technologists. The study included 83,655 female and 26,642 male radiologic technologists in the United States. All were certified for at least two years. The cohort was followed from the completion date of the first (1983 to 1989) or second survey (1994 to 1998) to the date of death, loss to follow-up, or Dec. 31, 2012, whichever was earliest. Occupational brain doses through 1997 were based on work history, historical data, and, for most years after the mid 1970s, individual film badge measurements. Radiation-related excess relative risks (ERRs) and 95 percent CIs were estimated from Poisson regression models adjusted for attained age and sex. The results showed the cumulative mean absorbed brain dose of the technologists was 12 mGy (range, 0 to 290 mGy). During follow-up of a median, 26.7 years, 193 technologists were noted to have died of a malignant intracranial neoplasm. Based on models incorporating a five-year lagged cumulative brain dose, cumulative brain dose was not associated with malignant intracranial tumor mortality, the researchers wrote. The researchers concluded cumulative occupational radiation exposure to the brain was not associated with malignant intracranial tumor mortality among this nationwide cohort of radiologic technologists.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
FDA Clears MRI-Based AI Segmentation of Organs at Risk During Radiation Therapy
May 2nd 2025Capable of segmenting over 37 organs and structures in the head, neck and pelvis, the MR Contour DL software is currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference.